LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lactate Concentrations Evaluated In Suspected Infections

By LabMedica International staff writers
Posted on 16 Oct 2012
Print article
The relationship between blood lactate concentrations categorized into groups and mortality appears to be linear, but the relationship between lactate as a continuous measurement and mortality is uncertain.

The prognostic significance of incremental blood lactate concentrations among emergency department (ED) patients with suspected infection has been evaluated and categorized into low, intermediate, and high groups.

Scientists at the University of Mississippi Medical Center (Jackson, MS, USA) carried out a retrospective cohort analysis of adult ED patients with suspected infection from a large urban ED during January 2007 to May 2011. Over the study period, 2,596 patients met inclusion criteria and the median age was 61 years, the median hospital length of stay was eight days and the overall mortality was 14.4%.

The whole blood lactate measurements were performed in the ED using the i-STAT point-of-care (POC) measurement (Abbott Point of Care Inc.; Princeton, NJ, USA; www.abbottpointofcare.com ). The median initial lactate concentration was 2.1 mmol/L, and 459 (17.6%) subjects had an initial lactate greater than 4 mmol/L. Mortality continued to rise across the continuum of incremental elevations, from 6% for lactate greater than 1.0 mmol/L up to 39% for lactate 19-20 mmol/L. Polynomial regression analysis showed a strong curvilinear correlation between lactate and mortality.

The authors concluded that in ED patients with suspected infection, incremental elevations in whole blood lactate values up to 20 mmol/L are associated with progressive increases in mortality. Clinicians should be aware of the prognostic significance of incremental increases in lactate, even in the significantly elevated range, and should avoid considering all patients with a high lactate to be at similar risk of death. The study was published on August 20, 2012, in the journal Academic Emergency Medicine.

Related Links:
University of Mississippi Medical Center
Abbott Point of Care Inc.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Sekisui Diagnostics UK Ltd.